Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course
Zhongchao Inc. (NASDAQ: ZCMD) announced the launch of its MDMOOC platform's online training course titled "Disease Prevention and Distribution Quality Management," aimed at enhancing skills in vaccination management for up to 20,000 healthcare staff. The course, launched in April 2022, is accessible through the MDMOOC website and WeChat platforms. Industry experts from various locations will lead the course, addressing key aspects of disease control and public health. Zhongchao remains committed to providing timely training for medical professionals in response to pandemic-related challenges.
- Launch of online training course expected to train up to 20,000 healthcare staff.
- Access available through multiple platforms including MDMOOC website and WeChat, increasing reach.
- Involvement of reputable experts enhances course credibility.
- None.
SHANGHAI, June 13, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patient management service, today announced its MDMOOC platform launched online training course (the "Course") titled "Disease Prevention and Distribution Quality Management," to staffs (the "Staffs") in various departments for diseases control and prevention, in order to improve their skillsets and efficiency in vaccination management as well as diseases control and prevention.
The Course was launched in April 2022 and is expected to provide trainings for up to 20,000 people. The targeted Staffs include Staffs from, among others, front-line clinics, communities, medical and administrative departments. Participants can access the Course through MDMOOC's website, the Company's WeChat public account, and the Company's WeChat mini program platform.
Speakers of the Course include representatives and experts in disease control, public health and medical science from Luzhou, Qingdao, Nanchong, Hangzhou, Guangzhou and Suzhou, and some well-known industry experts:
- Lingsheng Cao, the head of the National Immunization Planning Information Technology Working Group;
- Shicheng Guo, a member of the Field Epidemiology Group of the Public Health Branch of the Chinese Medical Association;
- Wenzhou Yu, a director of the Immunization Service Office of the National Center for Immunization Planning, and the chairman of the Special Committee on Immunization Service Guidance and Evaluation of the China Vaccine Industry Association; and
- Qin Tan, a member of the Vaccine Supply Assurance Branch of the China Vaccine Industry Association.
Since 2020, the Company has closely followed the policies and guidance regarding pandemic control and prevention issued by WHO and Chinese government and has launched related courses timely through its MDMOOC platform for medical professionals, regarding topics including but not limited to respiratory, emergency, mother-infant, psychological counselling, and other topics in the context of the epidemic. The Company will continue its efforts and commitments in providing state-of-the-art courses and trainings for medical workers and the general public in a timely manner.
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in the Cayman Islands. It conducts operations in China through the contractual arrangements between its wholly owned subsidiary and PRC operating entities. The PRC operating entities provide online healthcare information, professional training and educational services to healthcare professionals under their "MDMOOC" platform (www.mdmooc.org), offer patient management service on the professional field of tumor and rare diseases, and operate an online information platform, Sunshine Health Forums, to general public. More information about the Company can be found at its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training and educational services market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 21-3220-5987
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original content:https://www.prnewswire.com/news-releases/zhongchao-inc-announces-its-mdmooc-platform-launched-disease-prevention-and-distribution-quality-management-course-301566317.html
SOURCE Zhongchao Inc.
FAQ
What is the MDMOOC platform's new course launched by Zhongchao?
How many healthcare staff are expected to participate in the new MDMOOC course?
When was the new course on MDMOOC launched?
Who are the speakers for the MDMOOC training course?
What key topics does the MDMOOC course cover?
